Bellicum Pharmaceuticals (BLCM) Short Interest Ratio & Short Volume

Short interest is the volume of Bellicum Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 809,200 shares of BLCM short. Learn More on Bellicum Pharmaceuticals' current short interest.

Bellicum Pharmaceuticals saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 809,200 shares, a decrease of 43.8% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Bellicum Pharmaceuticals: Eiger BioPharmaceuticals, Inc. (2.27%), Evelo Biosciences, Inc. (2.11%), Sintx Technologies, Inc. (2.44%), Akanda Corp. (10.22%), Acorda Therapeutics, Inc. (0.66%), Invitae Co. (26.15%), Bone Biologics Co. (2.56%), SciSparc Ltd. (21.38%), Scinai Immunotherapeutics Ltd. (1.20%), Aditxt, Inc. (10.83%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.00 billion), Suncor Energy Inc. ($2.98 billion), Charter Communications, Inc. ($2.88 billion), Occidental Petroleum Co. ($2.79 billion), Moderna, Inc. ($2.39 billion), Snowflake Inc. ($2.38 billion), Coinbase Global, Inc. ($2.22 billion), Palantir Technologies Inc. ($2.18 billion), T. Rowe Price Group, Inc. ($2.03 billion), and Verisk Analytics, Inc. ($2.02 billion). View all of the most shorted stocks.

Short selling BLCM is an investing strategy that aims to generate trading profit from Bellicum Pharmaceuticals as its price is falling. BLCM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bellicum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLCM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLCM, twice per month. The most recent reporting period available is May, 31 2023.